The "fuzzy logic" of the death-inducing signaling complex in lymphocytes

被引:29
|
作者
Walsh, CM [1 ]
Luhrs, KA
Arechiga, AF
机构
[1] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Canc Res Inst, Irvine, CA 92697 USA
关键词
apoptosis; lymphocytes; T cells; caspases; death receptors;
D O I
10.1023/A:1025313415487
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Receptors belonging to the tumor necrosis factor receptor family have long been thought to play an important role in the regulation of immunity. Although this family is composed of a large number of surface receptors that potentiate myriad functions in vivo, a subset is known to directly convey apoptotic signals. One such molecule belonging to this subset is CD95. Ligation of CD95 instigates the formation of a complex known as the "death-inducing signaling complex" or DISC, which is composed of molecules including FADD (Fas associated with death domain) and RIP (receptor-interacting kinase), as well as procaspases-8 and -10, and a caspase-8-like molecule that lacks proteolytic activity called c-FLIP. Although the DISC was initially thought to serve an exclusively proapoptotic role, humans and mice with defects in various components of this complex demonstrate a variety of developmental and hematopoietic defects that are not apparently due to aberrant apoptosis. These findings paint a far more complex picture of the numerous components of the DISC, and provide evidence that these complexes serve nonapoptotic functions. Herein, we summarize the experimental evidence challenging the notion that the DISC imparts an exclusively apoptotic function and provide hypotheses to account for these alternative roles. Rather than operating as a binary system, we propose that the DISCs formed around various DRs transduce signals leading to a variety of cellular fates.
引用
收藏
页码:333 / 353
页数:21
相关论文
共 50 条
  • [1] The “Fuzzy Logic” of the Death-Inducing Signaling Complex in Lymphocytes
    Craig M. Walsh
    Keith A. Luhrs
    Adrian F. Arechiga
    Journal of Clinical Immunology, 2003, 23 : 333 - 353
  • [2] Death effecter domain for the assembly of death-inducing signaling complex
    Jin Kuk Yang
    Apoptosis, 2015, 20 : 235 - 239
  • [3] Death effecter domain for the assembly of death-inducing signaling complex
    Yang, Jin Kuk
    APOPTOSIS, 2015, 20 (02) : 235 - 239
  • [4] Dynamics within the CD95 death-inducing signaling complex decide life and death of cells
    Neumann, Leo
    Pforr, Carina
    Beaudouin, Joel
    Pappa, Alexander
    Fricker, Nicolai
    Krammer, Peter H.
    Lavrik, Inna N.
    Eils, Roland
    MOLECULAR SYSTEMS BIOLOGY, 2010, 6
  • [5] Calmodulin binding to the Fas-mediated death-inducing signaling complex on cholangiocarcinoma cells
    Chen, Yabing
    Pawar, Pritish
    Pan, George
    Ma, Liping
    Liu, Hui
    McDonald, Jay M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (03) : 788 - 799
  • [6] Death domain complex of the TNFR-1, TRADD, and RIP1 proteins for death-inducing signaling
    Park, Young-Hoon
    Jeong, Mi Suk
    Jang, Se Bok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (04) : 1155 - 1161
  • [7] Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells
    Fancy, Romone M.
    Kim, Harrison
    Zhou, Tong
    Zinn, Kurt R.
    Buchsbaum, Donald J.
    Song, Yuhua
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (08) : 2285 - 2294
  • [8] Partial equilibrium approximations in apoptosis. II. The death-inducing signaling complex subsystem
    Huang, Ya-Jing
    Hong, Liu
    Yong, Wen-An
    MATHEMATICAL BIOSCIENCES, 2015, 270 : 126 - 134
  • [9] cMet and fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cells
    Smyth, LA
    Brady, HJM
    HYPERTENSION, 2005, 46 (01) : 100 - 106
  • [10] Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway
    I Verbrugge
    E de Vries
    S W G Tait
    E H J Wissink
    H Walczak
    M Verheij
    J Borst
    Oncogene, 2008, 27 : 574 - 584